Michelle Lynn Hammer

Michelle Lynn Hammer ( MICHELLE LYNN HAMMER ) is Definition Nurse Practitioner Physician in Plainview, NE. The NPI Number for Michelle Lynn Hammer is 1427576651.

The current location address for Michelle Lynn Hammer is 106 S MAPLE ST STE 200 Plainview, NE 68769 and the contact number is 4025824797 and fax number is 4025823779. The mailing address for Michelle Lynn Hammer is 106 S MAPLE STREET, SUITE 200 PO BOX 544 Plainview, NE 68769- 4025824797 (mailing address contact number - 4025824797).

Definition to come...

What is the NPI Number for Michelle Lynn Hammer ?

Answer: The NPI Number for Michelle Lynn Hammer is 1427576651

Where is Michelle Lynn Hammer located?

Answer: Michelle Lynn Hammer is located at 106 S MAPLE ST STE 200 Plainview, NE 68769.

What is the specialty for Michelle Lynn Hammer ?

Answer: The Specialty of Michelle Lynn Hammer is Definition Nurse Practitioner Physician.

Are there any online reviews for Michelle Lynn Hammer ?

Answer: Not yet!

Are there any other health care providers in Plainview, NE?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Michelle Lynn Hammer

Number of HCPCS	11
Number of Medicare Beneficiaries	11
Number of Services	41
Total Submitted Charge Amount	6275.81
Total Medicare Allowed Amount	3219.1
Total Medicare Payment Amount	2035.49
Total Medicare Standardized Payment Amount	2195.89
Drug Suppress Indicator	*
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator	#
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries	69
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White Beneficiaries
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries	0
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaska Native Beneficiaries	0
Number of Beneficiaries With Race Not Elsewhere Classified	0
Number of Beneficiaries With Medicare & Medicaid Entitlement
Number of Beneficiaries With Medicare Only Entitlement
Percent (%) of Beneficiaries Identified With Atrial Fibrillation
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0
Percent (%) of Beneficiaries Identified With Asthma	0
Percent (%) of Beneficiaries Identified With Cancer	0
Percent (%) of Beneficiaries Identified With Heart Failure
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease
Percent (%) of Beneficiaries Identified With Depression
Percent (%) of Beneficiaries Identified With Diabetes
Percent (%) of Beneficiaries Identified With Hyperlipidemia
Percent (%) of Beneficiaries Identified With Hypertension
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease
Percent (%) of Beneficiaries Identified With Osteoporosis
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke	0
Average HCC Risk Score of Beneficiaries	0.904

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Nurse Practitioner
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	103
Number of Standardized 30-Day Fills	107
Aggregate Cost Paid for All Claims	16458.64
Number of Day's Supply for All Claims	2972
Number of Medicare Beneficiaries
Number of Claims, Including Refills, for Beneficiaries Age 65+	64
Including Refills, for Beneficiaries Age 65+	64
Beneficiaries Age 65+	9116.22
Number of Day's Supply for All Claims for Beneficaries Age 65+	1804
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	35
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	68
Aggregate Cost Paid for Generic Drugs	854.93
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst	*
Number of Claims for Beneficiaries Covered by MAPD Plans
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst	#
Number of Claims for Beneficiaries Covered by Standalone PDP Plans
Aggregate Cost Paid for Claims Filled by
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	39
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	7342.42
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	64
by Low-Income Subsidy	9116.22
Total Claims of Opioid Drugs, Including
Aggregate Cost Paid for Opioid Drugs
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms
Total Claims of Long-Acting Opioid Drugs
Aggregate Cost Paid for Long-Acting Opioid
Number of Day's Supply of All Long-Acting
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	63.166666667
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.4141666667